ns 1619 has been researched along with ns 004 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boissard, CG; Dworetzky, SI; Gao, Q; Gribkoff, VK; Li, Y; Martin, SW; Meanwell, NA; Natale, J; Romine, JL; Starrett, JE | 1 |
Boissard, CG; Dworetzky, SI; Gao, Q; Gribkoff, VK; Martin, SW; Meanwell, NA; Moon, S; Natale, J; Ortiz, A; Pajor, L; Romine, JL; Starrett, JE; Yeleswaram, S | 1 |
2 other study(ies) available for ns 1619 and ns 004
Article | Year |
---|---|
4,5-diphenyltriazol-3-ones: openers of large-conductance Ca(2+)-activated potassium (maxi-K) channels.
Topics: Animals; Crystallography, X-Ray; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channels; Models, Molecular; Molecular Conformation; Oocytes; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Structure-Activity Relationship; Triazoles; Xenopus laevis | 2002 |
3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SAR.
Topics: Animals; Brain; Crystallography, X-Ray; Female; In Vitro Techniques; Ion Channel Gating; Large-Conductance Calcium-Activated Potassium Channels; Molecular Structure; Oocytes; Oxadiazoles; Patch-Clamp Techniques; Plasma; Rats; Rats, Inbred SHR; Solubility; Stroke; Structure-Activity Relationship; Xenopus laevis | 2007 |